Cargando…

Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases

BACKGROUND: It has long been known that nasal inoculation with influenza A virus produces asymptomatic to febrile infections. Uncertainty persists about whether these infections are sufficiently similar to natural infections for studying human‐to‐human transmission. METHODS: We compared influenza A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bueno de Mesquita, Paul Jacob, Nguyen‐Van‐Tam, Jonathan, Killingley, Ben, Enstone, Joanne, Lambkin‐Williams, Robert, Gilbert, Anthony S., Mann, Alexander, Forni, John, Yan, Jing, Pantelic, Jovan, Grantham, Michael L., Milton, Donald K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767952/ https://www.ncbi.nlm.nih.gov/pubmed/32705798 http://dx.doi.org/10.1111/irv.12790

Ejemplares similares

Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment
por: Nguyen-Van-Tam, Jonathan S., et al.
Publicado: (2020)

Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community
por: Yan, Jing, et al.
Publicado: (2018)

The Effect of Influenza Virus on the Human Oropharyngeal Microbiome
por: Ramos-Sevillano, Elisa, et al.
Publicado: (2019)

Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections
por: Lau, Lincoln L. H., et al.
Publicado: (2010)

Qualitative Real-Time Schlieren and Shadowgraph Imaging of Human Exhaled Airflows: An Aid to Aerosol Infection Control
por: Tang, Julian W., et al.
Publicado: (2011)

Assessing Viral Shedding and Infectivity of Asymptomatic or Mildly Symptomatic Patients with COVID-19 in a Later Phase
por: Sohn, Yujin, et al.
Publicado: (2020)

Airflow Dynamics of Coughing in Healthy Human Volunteers by Shadowgraph Imaging: An Aid to Aerosol Infection Control
por: Tang, Julian W., et al.
Publicado: (2012)

Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2
por: Li, W., et al.
Publicado: (2020)

An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection
por: Lambkin-Williams, Rob, et al.
Publicado: (2016)

Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan
por: Lu, Yingying, et al.
Publicado: (2020)

Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea
por: Choi, Gawon, et al.
Publicado: (2022)

Viral RNA Shedding and Transmission Potential of Asymptomatic and Pauci-symptomatic COVID-19 Patients
por: Gupta, Ajay, et al.
Publicado: (2021)

Influenza Virus Aerosols in Human Exhaled Breath: Particle Size, Culturability, and Effect of Surgical Masks
por: Milton, Donald K., et al.
Publicado: (2013)

Is public transport a risk factor for acute respiratory infection?
por: Troko, Joy, et al.
Publicado: (2011)

Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols
por: Chen, Paul Z, et al.
Publicado: (2021)

Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir
por: Bray, Mike, et al.
Publicado: (2002)

Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai
por: Li, Ran, et al.
Publicado: (2023)

The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics
por: Lambkin-Williams, Rob, et al.
Publicado: (2018)

Editorial Commentary: Symptoms and Viral Shedding in Naturally Acquired Influenza Infections
por: Kwong, Jeffrey C.
Publicado: (2016)

SARS-CoV-2: The viral shedding vs infectivity dilemma
por: Widders, Arabella, et al.
Publicado: (2020)

LB6. Asymptomatic Infection and Duration of Viral Shedding in Symptomatic Breakthrough Infections in a Phase 3 Study of AZD1222 (ChAdOx1 nCoV-19)
por: Sobieszczyk, Magdalena, et al.
Publicado: (2021)

Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: A retrospective cohort study
por: Baek, Yae Jee, et al.
Publicado: (2022)

Leptospira infection and shedding in dogs in Thailand
por: Altheimer, Kerstin, et al.
Publicado: (2020)

Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants
por: Lai, Jianyu, et al.
Publicado: (2022)

Respirators versus medical masks: evidence accumulates but the jury remains out
por: Killingley, Ben
Publicado: (2011)

Viral Shedding and Environmental Cleaning in Middle East Respiratory Syndrome Coronavirus Infection
por: Song, Joon Young, et al.
Publicado: (2015)

Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection
por: Yang, Yang, et al.
Publicado: (2020)

Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration
por: Noh, Ji Yun, et al.
Publicado: (2020)

Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection
por: Bongiovanni, Marco, et al.
Publicado: (2021)

Viral shedding in gastroenteritis in children caused by variants and novel recombinant norovirus infections
por: Cheng, Hung-Yen, et al.
Publicado: (2021)

Chronological changes of viral shedding in adult inpatients with Omicron infection in Shanghai, China
por: Zhou, Xinru, et al.
Publicado: (2023)

Symptomatic, prolonged Parvovirus B19 infection and accompanying illness in otherwise healthy adults
por: Manfredi, Roberto
Publicado: (2010)

Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients
por: Buetti, Niccolò, et al.
Publicado: (2020)

Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control
por: Greatorex, Jane S., et al.
Publicado: (2011)

Viral Shedding in Patients Infected with Pandemic Influenza A (H1N1) Virus in Kenya, 2009
por: Waiboci, Lilian W., et al.
Publicado: (2011)

Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
por: Siedner, Mark J., et al.
Publicado: (2022)

Norovirus shedding among symptomatic and asymptomatic employees in outbreak settings in Shanghai, China
por: Wu, Qiang-song, et al.
Publicado: (2019)

Oral Bacterial Infection and Shedding in Drosophila melanogaster
por: Siva-Jothy, Jonathon A., et al.
Publicado: (2018)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
por: Yan, Dan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u9p5hgr6btlai6nprk08kv3nm4